Atezolizumab, CAS 1380723-44-3

Product Description: Atezolizumab (MPDL3280A) is a selective humanized monoclonal IgG1 antibody against programmed death ligand 1 (PD-L1), used for cancer research.

Applications: Cancer-programmed cell death

Formula: N/A

References: [1]Liu Z, et al. Targeting autophagy enhances atezolizumab-induced mitochondria-related apoptosis in osteosarcoma. Cell Death Dis. 2021;12(2):164. Published 2021 Feb 8./[2]Cha E, et al. PD-L1 inhibition with MPDL3280A for solid tumors. Semin Oncol. 2015 Jun;42(3):484-7.

CAS Number: 1380723-44-3

Molecular Weight: N/A

Compound Purity: 98.98

Research Area: Cancer

Solubility: H2O

Target: Apoptosis;Autophagy;PD-1/PD-L1

• SKU: MEXHY-P9904-5
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-P9904-5
• Green Labware: No
• Package Unit: 5 mg
• Quantity Unit: STK